Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges

Published:2019-01 Issue:2 Volume:156 Page:431-445
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Baumert Thomas F.,Berg Thomas,Lim Joseph K.,Nelson David R.

Funder

National Institutes of Health

US Department of Defense

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

National Institutes of Health National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference119 articles.

1. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis;Kowdley;N Engl J Med,2014

2. Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the Veterans Affairs National Health Care System;Ioannou;Gastroenterology,2016

3. Effectiveness of ledipasvir-sofosbuvir combination in patients with hepatitis C virus infection and factors associated with sustained virologic response;Terrault;Gastroenterology,2016

4. Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients;Curry;Aliment Pharmacol Ther,2017

5. Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection;Zeuzem;N Engl J Med,2018

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hijacking autophagy for infection by flaviviruses;Virus Research;2024-09

2. An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection;Nature Communications;2024-08-29

3. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

4. A therapeutic approach for the hepatitis C virus: in silico design of an antisense oligonucleotide-based candidate capsid inhibitor;Virus Genes;2024-07-31

5. Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment;The Journal of Infection in Developing Countries;2024-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3